Egrifta and Lasix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Egrifta (tesamorelin acetate) and Lasix (furosemide). Common drug interactions include joint swelling among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Egrifta and Lasix. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Egrifta?

Egrifta has active ingredients of tesamorelin acetate. eHealthMe is studying from 3,443 Egrifta users. Check the latest studies of Egrifta.

What is Lasix?

Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 210,439 Lasix users. Check the latest studies of Lasix.

On Jul, 11, 2026

20 people who take Egrifta and Lasix together, and have interactions are studied.

What are the common drug interactions of Egrifta and Lasix, by gender? *:

female:

Joint swelling
Arthralgia (joint pain)
Blood glucose increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac disorder
Cardiac failure
Chest discomfort
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dizziness

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Osteonecrosis (death of bone)
Osteopenia (a condition where bone mineral density is lower than normal)
Diarrhoea
Drug ineffective
Acute myocardial infarction (acute heart attack)
Cellulitis (infection under the skin)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Egrifta and Lasix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hip arthroplasty
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Bone loss
Chronic kidney disease
Emotional distress
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Renal failure (kidney dysfunction)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Pain
Renal failure (kidney dysfunction)
Osteonecrosis (death of bone)
Acute myocardial infarction (acute heart attack)
Arthralgia (joint pain)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

Diarrhoea
Drug ineffective
Eye disorder
Gait disturbance
Ill-defined disorder
Joint swelling
Oedema peripheral (superficial swelling)
Photopsia (presence of perceived flashes of light)
Sinusitis (inflammation of sinus)
Blood glucose increased

What are the existing conditions these people have? *

Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 9 people, 45.00%
Hiv Infection: 9 people, 45.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 20.00%
Waist Circumference Increased: 1 person, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Egrifta and Lasix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously